Zealand Pharma A/S (ZEAL) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zealand Pharma A/S

    NASDAQ: ZEAL · Real-Time Price · USD
    17.59
    0.00 (0.00%)
    At close: Sep 29, 2022, 10:00 PM

    Zealand Pharma A/S Ratios and Metrics

    Financials in DKK. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    PE Ratio
    		 -5.26
    PEG Ratio
    		 -0.26
    PS Ratio
    		 18.30
    PB Ratio
    		 5.77
    P/FCF Ratio
    		 -4.34
    P/OCF Ratio
    		 -4.42
    OCF/S Ratio
    		 -4.14
    Debt / Equity Ratio
    		 0.85
    Quick Ratio
    		 4.80
    Current Ratio
    		 5.15
    Asset Turnover
    		 0.14
    Interest Coverage
    		 -250.02
    Return on Equity
    		 -1.1
    Return on Assets
    		 -0.49
    Return on Invested Capital
    		 -0.58
    Dividend Yield
    		 n/a
    Payout Ratio
    		 n/a
    Gross Profit Margin
    		 0.59
    Net Profit Margin
    		 -3.48
    Pretax Profit Margin
    		 -3.51
    Operating Profit Margin
    		 -3.5
    FCF Margin
    		 n/a
    EBITDA Margin
    		 -3.36

    Add to Watchlist